Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
podcast
Podcast
What’s ahead for biopharma and healthcare in 2026
Fierce reporters break down the forces that shaped biopharma and healthcare in 2025 and what lies ahead in 2026.
Ayla Ellison
,
Darren Incorvaia
,
Gabrielle Masson
,
Fraiser Kansteiner
,
Angus Liu
,
Eric Sagonowsky
,
Ben Adams
,
James Waldron
,
Heather Landi
,
Paige Minemyer
Dec 19, 2025 10:00am
Using Patient Engagement and Digital Innovation to Elevate Patient Insights and Outcomes
Dec 19, 2025 12:00am
What to Expect at the 2026 Patients as Partners in Clinical Research Conference
Dec 18, 2025 12:00am
Leveraging Local HCPs to Decentralize Clinical Research in North Carolina
Dec 17, 2025 12:00am
What is the State of Clinical Trial Patient Matching Right Now?
Dec 16, 2025 12:00am
Advances in Payload Delivery and Drug Conjugation
Dec 12, 2025 12:00am